Ignite Creation Date:
2025-12-24 @ 1:30 PM
Ignite Modification Date:
2026-02-25 @ 2:31 AM
Study NCT ID:
NCT00464295
Status:
COMPLETED
Last Update Posted:
2007-12-14
First Post:
2007-04-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)
Sponsor:
Aga Khan University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
449-Med/ERC-05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Muhammad Kashif Anis
Old Organization:
Aga Khan University